These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 17185363)

  • 1. Circulating concentrations of growth-differentiation factor 15 in apparently healthy elderly individuals and patients with chronic heart failure as assessed by a new immunoradiometric sandwich assay.
    Kempf T; Horn-Wichmann R; Brabant G; Peter T; Allhoff T; Klein G; Drexler H; Johnston N; Wallentin L; Wollert KC
    Clin Chem; 2007 Feb; 53(2):284-91. PubMed ID: 17185363
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Highly specific detection of myostatin prodomain by an immunoradiometric sandwich assay in serum of healthy individuals and patients.
    Breitbart A; Scharf GM; Duncker D; Widera C; Gottlieb J; Vogel A; Schmidt S; Brandes G; Heuft HG; Lichtinghagen R; Kempf T; Wollert KC; Bauersachs J; Heineke J
    PLoS One; 2013; 8(11):e80454. PubMed ID: 24260393
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Circulating concentrations of follistatin-like 1 in healthy individuals and patients with acute coronary syndrome as assessed by an immunoluminometric sandwich assay.
    Widera C; Horn-Wichmann R; Kempf T; Bethmann K; Fiedler B; Sharma S; Lichtinghagen R; Leitolf H; Ivandic B; Katus HA; Giannitsis E; Wollert KC
    Clin Chem; 2009 Oct; 55(10):1794-800. PubMed ID: 19574466
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic utility of growth differentiation factor-15 in patients with chronic heart failure.
    Kempf T; von Haehling S; Peter T; Allhoff T; Cicoira M; Doehner W; Ponikowski P; Filippatos GS; Rozentryt P; Drexler H; Anker SD; Wollert KC
    J Am Coll Cardiol; 2007 Sep; 50(11):1054-60. PubMed ID: 17825714
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Elevated circulating growth differentiation factor 15 is related to decreased heart rate variability in chronic kidney disease patients.
    Wang L; Luo J; Liu W; Huang X; Xu J; Zhou Y; Jiang L; Yang J
    Ren Fail; 2021 Dec; 43(1):340-346. PubMed ID: 33567936
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Growth differentiation factor 15 is related to anemia and iron metabolism in heart allograft recipients and patients with chronic heart failure.
    Przybyłowski P; Wasilewski G; Bachorzewska-Gajewska H; Golabek K; Dobrzycki S; Małyszko J
    Transplant Proc; 2014 Oct; 46(8):2852-5. PubMed ID: 25380934
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reference change values and determinants of variability of NT-proANP and GDF15 in stable chronic heart failure.
    Frankenstein L; Remppis A; Frankenstein J; Hess G; Zdunek D; Gut S; Slottje K; Katus HA; Zugck C
    Basic Res Cardiol; 2009 Nov; 104(6):731-8. PubMed ID: 19352585
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Growth differentiation factor 15 in heart failure with preserved vs. reduced ejection fraction.
    Chan MM; Santhanakrishnan R; Chong JP; Chen Z; Tai BC; Liew OW; Ng TP; Ling LH; Sim D; Leong KT; Yeo PS; Ong HY; Jaufeerally F; Wong RC; Chai P; Low AF; Richards AM; Lam CS
    Eur J Heart Fail; 2016 Jan; 18(1):81-8. PubMed ID: 26497848
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Circulating levels of cardiac natriuretic peptides (ANP and BNP) measured by highly sensitive and specific immunoradiometric assays in normal subjects and in patients with different degrees of heart failure.
    Clerico A; Iervasi G; Del Chicca MG; Emdin M; Maffei S; Nannipieri M; Sabatino L; Forini F; Manfredi C; Donato L
    J Endocrinol Invest; 1998 Mar; 21(3):170-9. PubMed ID: 9591213
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Growth differentiation factor-15 and metabolic features in chronic heart failure: Insights from the SUPPORT Trial -GDF15 across the BMI spectrum.
    Teramoto K; Nochioka K; Sakata Y; Kato ET; Nishimura K; Shimokawa H; Yasuda S;
    Int J Cardiol; 2024 Jul; 407():132093. PubMed ID: 38663803
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Elevated level of serum growth differentiation factor 15 is associated with oral leukoplakia and oral squamous cell carcinoma.
    Yang CZ; Ma J; Luo QQ; Neskey DM; Zhu DW; Liu Y; Myers JN; Zhang CP; Zhang ZY; Zhong LP
    J Oral Pathol Med; 2014 Jan; 43(1):28-34. PubMed ID: 23710769
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Growth differentiation factor 15, ST2, high-sensitivity troponin T, and N-terminal pro brain natriuretic peptide in heart failure with preserved vs. reduced ejection fraction.
    Santhanakrishnan R; Chong JP; Ng TP; Ling LH; Sim D; Leong KT; Yeo PS; Ong HY; Jaufeerally F; Wong R; Chai P; Low AF; Richards AM; Lam CS
    Eur J Heart Fail; 2012 Dec; 14(12):1338-47. PubMed ID: 22869458
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multi-center determination of galectin-3 assay performance characteristics: Anatomy of a novel assay for use in heart failure.
    Christenson RH; Duh SH; Wu AH; Smith A; Abel G; deFilippi CR; Wang S; Adourian A; Adiletto C; Gardiner P
    Clin Biochem; 2010 May; 43(7-8):683-90. PubMed ID: 20153309
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of serum level of growth differentiation factor 15 with liver cirrhosis and hepatocellular carcinoma.
    Liu X; Chi X; Gong Q; Gao L; Niu Y; Chi X; Cheng M; Si Y; Wang M; Zhong J; Niu J; Yang W
    PLoS One; 2015; 10(5):e0127518. PubMed ID: 25996938
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Circulating concentrations of fibroblast activation protein α in apparently healthy individuals and patients with acute coronary syndrome as assessed by sandwich ELISA.
    Tillmanns J; Widera C; Habbaba Y; Galuppo P; Kempf T; Wollert KC; Bauersachs J
    Int J Cardiol; 2013 Oct; 168(4):3926-31. PubMed ID: 23932048
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Growth differentiation factor 15 increases following oral glucose ingestion: effect of meal composition and obesity.
    Schernthaner-Reiter MH; Kasses D; Tugendsam C; Riedl M; Peric S; Prager G; Krebs M; Promintzer-Schifferl M; Clodi M; Luger A; Vila G
    Eur J Endocrinol; 2016 Dec; 175(6):623-631. PubMed ID: 27926473
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasma GDF15 level is elevated in psychosis and inversely correlated with severity.
    Kumar P; Millischer V; Villaescusa JC; Nilsson IAK; Östenson CG; Schalling M; Ösby U; Lavebratt C
    Sci Rep; 2017 Aug; 7(1):7906. PubMed ID: 28801589
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum Growth Differentiation Factor 15 in Parkinson Disease.
    Yao X; Wang D; Zhang L; Wang L; Zhao Z; Chen S; Wang X; Yue T; Liu Y
    Neurodegener Dis; 2017; 17(6):251-260. PubMed ID: 28787735
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical and analytical evaluation of an immunoradiometric assay for corticotropin.
    Rosano TG; Demers LM; Hillam R; Dybas MT; Leinung M
    Clin Chem; 1995 Jul; 41(7):1022-7. PubMed ID: 7600682
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasma brain natriuretic peptide measured by fully-automated immunoassay and by immunoradiometric assay compared.
    Del Ry S; Giannessi D; Clerico A
    Clin Chem Lab Med; 2001 May; 39(5):446-50. PubMed ID: 11434395
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.